Lucid Diagnostics (LUCD) Income towards Parent Company (2020 - 2026)

Lucid Diagnostics has reported Income towards Parent Company for 7 years, with the latest figure at -$13.9 million in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company rose 48.31% year-over-year to -$13.9 million; the trailing twelve-month figure through Mar 2026 stood at -$45.0 million (up 27.2% YoY), and the FY2025 full-year result was -$58.0 million, down 27.41% from the prior year.
• Income towards Parent Company for Q1 2026 stood at -$13.9 million, up from -$16.3 million in the prior quarter.
• The five-year high for Income towards Parent Company was -$4.4 million in Q2 2025, with the low at -$26.9 million in Q1 2025.
• Historically, Income towards Parent Company has averaged -$13.3 million across 5 years, with a median of -$12.4 million in 2024.
• Annual changes were most pronounced in 2022 — Income towards Parent Company slumped 235.89% — and 2025, when it jumped 59.66%.
• Lucid Diagnostics' Income towards Parent Company stood at -$14.9 million in 2022, then rose by 27.45% to -$10.8 million in 2023, then decreased by 6.57% to -$11.5 million in 2024, then plunged by 40.94% to -$16.3 million in 2025, then rose by 14.49% to -$13.9 million in 2026.
• The last three Income towards Parent Company figures came in at -$13.9 million (Q1 2026), -$16.3 million (Q4 2025), and -$10.4 million (Q3 2025), per Business Quant data.